Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV).

Mohamed Bouchahda,Valérie Boige,Denis Smith,Abdoulaye KarabouÃ,Mohamed Hebbar,Céline Lepère,C. Focan,Rosine Guimbaud,Pasquale F. Innominato,S. Awad,Carlos Carvalho,Salvatore Tumolo,Stéphanie Truant,Thierry de Baere,Denis Castaing,Philippe Rougier,Julien Taieb,Jean F. Morere,Michel Ducreux,Francis Lévi

Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV).

2016

e15036Background: Early tumor shrinkage has been associated with improved long-term outcome in patients (pts) with chemotherapy (chemo)-refractory LM-CRC. We examined the prognostic relevance of ea...

Keywords:

Cetuximab
Pathology
Fluorouracil
KRAS
Artery infusion
Oncology
Oxaliplatin
Colorectal cancer
Chemotherapy
Medicine
Irinotecan
Internal medicine
systemic chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations